ANTA BIOTECHNOLOGIES CORPORATION
Medtech · Private
Automated, miniaturized, gravity-agnostic system for DNA extraction and preparation for sequencing
- Grants
- $1.5M
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $174K
- 1 award · NASA
- #466 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Autonomous System for DNA Sequencing Prep in Space and Austere Environments | $275,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Autonomous System for DNA Sequencing Prep in Space and Austere Environments | $1,229,393 | |
| Federal contract | National Aeronautics and Space Administration · SBIR 1AUTOMATED Dna Extraction In Space | $174,499 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 463 | LEDA HEALTH CORPORATION | $184K | $9.4M |
| 464 | MX3 DIAGNOSTICS, INC. | $181K | — |
| 465 | INTAN TECHNOLOGIES, LLC | $177K | — |
| 466 | ANTA BIOTECHNOLOGIES CORPORATION | $174K | — |
| 467 | TWINSTRAND BIOSCIENCES INC | $174K | $85M |
| 468 | ISCIENCE INTERVENTIONAL CORP | $174K | $24M |
| 469 | EVREN TECHNOLOGIES, INC. | $172K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.